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Predicting Mammalian Mutagenesis by
Submammalian Assays: An Application
of Database GEN
by F. E. Wurgler*
Adatabasecontainingqualitativeinformationonthegenotoxicactivity ofabout3000chemicalsisdescribed. Thein-
itial aimfortheconstructionofthedatabase wastodevelopaninstumntforcomparingtheperformanceofdifferent
genotodcityassay systems. OneappLicationofthedatabase isthepredictionofexpecedresultsinanygo idt assay
forchemicalsthatweretestedinasmallnumberofgenotoccity assays.ITeBayesianp n is alculated basedon
thesensitivitiesandspecifdtiesbetweenany redtivetestandthebtgettestforwhich the dionistobedetermined.
Thepredictivity ofthesystemforin vivom malian assaysisat present (withtheexceptionofthemicronucleusassay
andtheinviosisterchromatidexchanges)l d,inpriulrbecauseofthelmited numberofchemicals testedinthe
expensiveinWivoassaysand, inaddition, duetothelackofsufficientinformationonnegativecompounds. Acontinued
updatingofthedatabase willpossibly helptoovercome someofthe presentdifficulties.
Introduction
Theaimofgenetictoxicology istodetectthosechemical com-
pounds capable of inducing genetic damage in man. This
category ofchemicalsincludes, asthemajorcomponentsknown
today, the potential human germ cell mutagens as well as the
genotoxic carcinogens. For anumberofreasons, directtests in
humans are impossible. Therefore, model systems have to be
used. Ingeneral, thein vivo systems nearest tothehumansitua-
tionthat canbeused on alarge scale arerodentmodels, in par-
ticularthe mouse. For anumberofreasons, e.g., highcosts, long
durationofexperiments, andreductionofthe useofexperimental
animals for ethical reasons, ithas become anongoing effort to
replace atleastpartofthein vivotestsbyexperiments withsub-
mammalian species and/orin vitro assays. Beforerelying onthe
results of the short-term tests (STTs), these tests have to be
validated against the results obtained with in vivo systems and
where possible against information available forhumans.
Everypossibleeffort wasmadetoevaluatetheSTTs aspredic-
tive tests forcarcinogenic potential. Forthis purpose, theresults
of STTs were compared with the results obtained in rodent
lifetimecarcinogenicity studies. To ourknowledge, nosimilar,
systematic studieshavebeenundertaken sofar inordertovalidate
the STTs fortheirpredictivity forgenotoxiceffectsobservedin
animal models in vivo. Such studies maybehelpful indeciding
whichSTTsmightbeoptimal substitutes forin vivomammalian
genotoxicity tests.
Theavailablegenotoxicity assaysdifferinimportantbiological
parameters, such aspharmacokineticsandmetabolism, aswell
*Institute ofToxicology, SwissFederal InstituteofTechnologyandUniversity
ofZurich, Schroenstmsse 16, CH-8603 Schwerzenbach nearZurich, Switzerland.
asthegeneticendpointsstudied. ThedatabaseGENmaybeused
forcomparisonsofgenotoxicityassays. Someexperiencegained
is reported here.
The Database GEN
Each chemical in the database GEN is characterized by the
ChemicalAbstractsServicesRegistryNumber(CASRN). The
assays includedandthemajorsourcesofinformationaregiven
inTable 1. Resultsfromanyindividualassayorsubassayarecod-
edas 1 fornegative; 2forinconclusive; and3 forpositive. Miss-
ingdataarecodedas0. Thecode 1 + 3representstheconclusive
results; thecode 1 + 2 + 3 represents thenonzeroresults. For
future versions ofthe program, the introduction of4 for weak
positive willbeconsidered.
CASRNsandthenamesofthechemicalsarecontainedinone
file; CASRNsandassayresultsareinanotherfile. Table 1 gives
thelistofthemajorgroupsofgenotoxicityassaysandgeneticend
points included inthedatabase.
Thedatacontained inthedatabasehavebeenpredominantly
takenfromthefollowingsources: Gene-Toxreports,publications
oftheU.S. National Toxicology Program (NTP) (inparticular
the results ofDrosophila assays), International Collaborative
Studies, somereviews, andthedatabasepublishedbyPalajdaand
Rosenkranz (1).
The Software
ThesoftwareiswritteninFortran77andrunsona8700VAX
of the Computing Center of the Swiss Federal Institute of
TechnologyinZurich. Thefeaturesofthesoftwarearediscussed
below.F. E. WURGLER
ITable 1. Majorgroupsofassays included inthedatabase GEN.
Code Assay Code Assay
E. coli rec assay DES Drosophila melanogaster eye assay single spots
E. coli DNA repair DET Drosophila melanogaster eye assay twin spots
B. subtilis repair DEU Drosophila melanogaster unstable eye system
Induc test (lambda induction in E. coli) DUE Drosophila melanogaster unstable eye system (exr-)
SOS chromotest with activation DWA Drosophila melanogaster wing assay all spots
SOS chromotest without activation DWS Drosophila melanogasterwing assay small single spots
Proteus miriabilis DNA repair DWL Drosophila melanogasterwing assay large single spots
umu test with activation DWT Drosophila melanogaster wing assay twin spots
umu test without activation DWE Drosophila melanogasterwing assay all spots (exr-)
Unscheduled DNA synthesis CHO Specific gene mutations in Chinese hamster ovary cells
DNA repair assay using eukaryotic systems V79 Specific gene mutations in V79 Chinese hamstercells
Salmonella mutagenicity assay (all strains) Mly Specific gene mutations in mouse lymphoma L5178Y cells
S. typhimurium TA 98 with activation Cvt Mammaliancytogenetics in vitro
S. typhimurium TA 100 with activation MCC Mammalian cell culture aneuploidy (hyperploidy)
S. typhimurium TA 102 with activation DLA Dominant lethal assay
S. typhimurium TA 1535 with activation Mnt Micronucleus test
S. typhimurium TA 1537 with activation Htr Heritabletranslocations in the mouse
S. typhimurium TA 1538 with activation Msl Mouse specific locus test
S. typhimurium TA 98 without activation Msp Mouse spot test
S. typhimurium TA 100 without activation Cbm Bone marrow cytogenetics in vivo
S. typhimurium TA 102 without activation Cle In vivoleukocyecytogenetics
S. typhimurium TA 1535 without activation Cco In viooocyte cytogenetics
S. typhimurium TA 1537 without activation Csg In vWvospermatogonia cytogenetics
S. typhimurium TA 1538 without activation Csp In vivo spermatocyte cytogenetics
E. coli WP2 reverse mutation assay MFG Mammalian female gern cells aneuploidy (hyperploidy)
Pooleddata from Saccharomyces cerevisiae (all assays) MMG Mammalian male germcells aneuploidy (hyperploidy)
Saccharomyces cerevisiae forward mutations MSC Mammalian somatic cells in vivoaneuploidy (hyperploidy)
Saccharomyces cerevisiae reverse mutations SAB Spermabnormality assay
Saccharomyces cerevisiae homozygosis (recombination orconversion) SCE Sisterchromatid exchanges (all assays)
Saccharomyces cerevisiae gene conversion SCT Sisterchromatidexchanges in vitro
Saccharomyces cerevisiae mitotic recombination SCV Sister chromatidexchanges in vio
Saccharomyces cerevisiae aneuploidy SCW Sister chromatidexchanges (all assays including weak responses)
Saccharomyces cerevisiae mitochondrial mutations STW Sister chromatidexchanges in vitro including weak responses
Genetic effects in Schizosaccharomycespombe SVW Sisterchromatidexchanges in vio including weak responses
Neurospora crassa aneuploidy HMA Host-mediated mutagenicity assay
Aspergillus nidulansaneuploidy Bfl Mutagenicity assay using body fluids
Pooleddata from Drosophila melanogaster PAN Plant systems aneuploidy
Drosophila melanogaster sex-linked recessive lethal test BHK Transformation ofBHK21 cells
Drosophila heritable translocations 3T3 Balb/C-3T3 neoplastic transformation assay
Drosophila melanogaster chromosome mutation SHE Transformation ofSyrian hamsterembryo cells
Drosophila melanogasterclastogenicity C3H TranslormationofC3H cells
Drosophila melanogasteraneuploidy (Dellarco table) MpR Mouse prostate transformation assay
Drosophila melanogasteraneuploidy Vet Viral enhancement systems (transformation assay)
Drosophila melanogaster nondisjunction gain IME Inhibitionofintracellular molecularexchange
Drosophila melanogaster nondisjunction loss PRO Promoting activity
Pooled data from SMART assays (eye and/or wing) ACR Animal carcinogens
Drosophila melanogaster eye assay all spots HCR Humancarcinogens
Applications. DATA RETRIEVAL. Data retrieval routines allow
onetoobtain, for any chemical definedby itsCASRN, alist con-
taining all nonzero assay results stored in the database. Because
theprimarygoal inconstructing thedatabase was todevelop an
instrument for comparisons of assays and to calculate predic-
tions, no references to originalpublications were included. The
program contains, however, with every assaydescription, alist
ofthe secondary sources from which data have been obtained.
In theprintout, this listisprintedtogetherwiththeassaydescrip-
tion, and itallows, althoughwith limitedconvenience, onetofind
the originalpublication containing theoriginal information by
checking the secondary sources.
Another feature of the program allows one to get lists of
chemicals showing any predeterminedpatternofgenotoxic ac-
tivity (e.g., the chemicalspositive withactivation inSalmonella
TA98 and TA100, but negative in the in vivo bone marrow
micronucleustest). This feature is helpful if, in atestingprogram,
unexpectedcombinationsoftestresults areobtained. Alistofthe
chemicalsshowingthe same or a very similar pattern may help
onetodevelop anexperimentallytestablehypothesis toexplain
the basis ofthe unexpected pattern.
Incertaininstances, itis interesting to get a listofchemicals
givingoppositeresults intwoparticular assays (e.g., negativefor
genemutationbutpositiveforrecombination). In the samebasis,
itispossible, byselectingpairsofin vitro assayswithandwithout
metabolicactivation, tocheckwhichcompoundsneedmetabolic
activation and which aredirect-acting mutagens.
Forspecial purposes, itispossible toget adumpofthewhole
database with the original codes attached to every individual
chemical and a summary for every individual chemical on the
number of nonzero, conclusive, positive, negative, and in-
conclusive assay results present.
INFORMATIONONASSAYs. By selectingthecodefor aparticular
genetic end point in one particular assay and the code for the
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assay result (positive, negative, inconclusive, orany combina-
tion thereof), one can obtain a list, in CASRN order, of all
chemicals testedintheassayleadingtotheparticulartestresult.
At the end of the list, the total number ofchemicals found is
given.
IINFORMATION ONASETOFASSAYS. Thedatabase canbeused to
calculatetheHemmingdistancesbetweenanypairofassays. The
distancematrixcanbestructuredinsuchawaythatitcanserve
asinputtoBMDP. WiththeBMDPprogram (2), aclusteranal-
ysiscanbeperformed. Inoneapplicationwecomparedthedif-
ferent assays used todetectchemically induced recombination
in different organisms. Comparing the Drosophila and yeast
data, theanalysisindicatesthattheresultsfromtheDrosophila
somatic assays appeartobemore similartotheyeastgenecon-
version data than to the yeast mitotic recombination data.
Because gene conversion is, so far, only known to occur in
meioticcellsofDrosophila, thisresultencouragedustoinitiate
studies aimed at detecting somatic gene conversion in Dro-
sophila. Anothertechnique togetsomeinformationonthecom-
parative performance ofa set ofassays is the determination of
kappa values forpairs ofassays (3).
PREDICTING ASSAY RESULTS. Theoretically, the information
contained inthedatabasecanbeusedtocalculatepredictionsfor
theoutcomeofanygenotoxicity assayforanychemicalforwhich
minimal information onitsgenotoxic potential isavailable, e.g.,
forwhichatleastonegenotoxicity assayhasbeenperformed. As
moreexperimental information isavailable, theprecisionofthe
predictions improves.
Definitions. Tests are all the assays (with their individual
genetic endpoints) contained inthedatabase. Thetarget testis
theparticulargeneticendpointofanassayforwhichthepredic-
tion is to becalculated.
Method. ThepredictionsarecalculatedbyapplyingtheBayes'
theorem tothe sensitivities and specificities calculated forany
pairofassaysavailableinthedatabase. Sensitivitydescribeswhat
fraction ofchemical found positive inthe target assay was also
positiveinthepredictiveassay. Specificitydescribes whatfrac-
tionofchemicalsnegativeinthetargettest wasalsonegative in
thepredictive assay. TheBayesiananalysisisdescribedindetail
by Pet-Edwards et al. (4,5).
Predictionsfor Chemicals Present in theDatabase. For any
chemical thathas atleastoneentry inthedatabase, thepredic-
tionforany testmaybecalculated. Theprocedureisasfollows:
a)SelectthechemicalbyenteringtheCASRN. Thenthesystem
presentsonthescreenalltheassayresultsforthischemicalthat
areinthedatabaseandwhichmightbeusedtocalculateapredic-
tion. b) Then the test for which the result should be predicted
(target test) is selected. As the system knows the target test, it
starts tocalculate alltherelevant sensitivities andspecificities,
that is, those between the target test and any test for which the
chemicalhasexperimentaldata. Thefactthatthesensitivitiesand
specificities arecalculatedwitheveryapplicationmakessurethat
wehave alearning systemmaking useimmediately ofany new
dataenteredintothedatabase. Fortheadjustmentofsensitivities
andspecificitiesbasedonsmallnumbersofchemicals andthose
withnumericalvaluesof1.0and0.0, theproceduredescribedby
EnneverandRosenkranz(6)wasused. Thesystemnowclassifies
theassaysavailable forthecalculationofthepredictions accor-
ding to high and low values for the sensitivity and specificity
(4-6). c) The prediction for the result expected in the target
test may be calculated based onall predictive tests available or
byusingonlysomeselectedtests, e.g., selectedaccordingtotheir
classification.
Applications. The applications approach may be used to
predict a nonexisting result, orto check the expectation, ifex-
perimentally aninconclusive resultwasobtained, ortocheckthe
degreeofconfidenceforaconclusiveresult(e.g., anunexpected
negative result).
For an exploratory data analysis, the system allows one to
change, temporarily, oneormoreassay results forthechemical
understudy. Thisallowsonetostudythechangeinpredictionif
apredictiveassay with aninconclusive resultwouldhavehad a
positiveoranegativeresponse, forexample. Oronemaycheck
thechange inprediction (e.g., forcarcinogenicity as the target
test)andhowthepredictionwouldbeimprovedbyadding anad-
ditionalconclusive resultfromanot-yetperformedassay. Inthis
wayonemightdecidewhetherthetestwouldadduseful informa-
tion to the genotoxic profile ofthe chemical and whether it is
worth conducting the actual experiment.
Athirdapplicationallowsonetoentertheinformationonassay
results forachemical notpresentinthedatabase. Thisinforma-
tionisnotincludedinthedatabaseanddisappearsastheapplica-
tion is terminated. Upon selection ofthe targettest, the system
uses the database to calculate the relevant sensitivities and
specificities, and theanalysis continues as described above.
Experiences. Inconnectionwiththeattemptstoreduceanimal
experiments, webecameinterested inusingoursystemto study
the predictivity of STTs not only for carcinogenesis but for
genotoxiceffectsinanimalsin vivo(inparticular, themouse). To
makealongstory short, wefindthatforthein vivomicronucleus
test and the in vivo sister chromatid exchange test, fairly
reasonable predictions are possible, but for the other in vivo
assays, suchasthemousespecificlocustest, themouseheritable
translocationtest, andthemousespottest, predictionshavenot
yet been possible. The reasons for this are a) that a relatively
small numberofchemicals tested intheseassays arecontained
inthedatabase, b) thesechemicals have notbeensystematical-
ly tested in the STT, and c) the number ofchemicals reported
negative in an in vivo assay is limited, thus the calculation of
reliablesensitivitiesandspecificitiesbecomesthemajorproblem.
BecausethedatabaseispredominantlybasedontheGene-Tox
reports, we expect that an update ofthe database with the data
published after the completion ofthe Gene-Tox phase 1 might
leadtosomeimprovementsofthesystemtostudypredictionsfor
the in vivo assays otherthancarcinogenicity.
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